771580-70-2 Usage
General Description
"[4-(Trifluoromethyl)pyridine-3-yl]methylamine" is a chemical compound with the molecular formula C8H8F3N. It is a derivative of pyridine and contains a methylamine group attached to the 3-position of the pyridine ring, as well as a trifluoromethyl group at the 4-position. [4-(Trifluoromethyl)pyridine-3-yl]methylamine is often used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. The trifluoromethyl group can enhance the lipophilicity and metabolic stability of the molecule, making it a valuable tool for drug discovery and development. Additionally, the presence of the pyridine ring gives the compound potentially useful pharmacological properties, such as binding to specific receptors or enzymes. Overall, [4-(Trifluoromethyl)pyridine-3-yl]methylamine is a versatile chemical that finds applications in various fields including medicine, agriculture, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 771580-70-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,1,5,8 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 771580-70:
(8*7)+(7*7)+(6*1)+(5*5)+(4*8)+(3*0)+(2*7)+(1*0)=182
182 % 10 = 2
So 771580-70-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H7F3N2/c8-7(9,10)6-1-2-12-4-5(6)3-11/h1-2,4H,3,11H2
771580-70-2Relevant articles and documents
CB1 MODULATOR COMPOUNDS
-
Page/Page column 60, (2008/06/13)
Novel compounds of structural formula (I) are disclosed. As modulators of the Cannabinoid-1 (CB1) receptor, these compounds are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. As such, compounds of the present invention are useful as in the treatment, prevention and suppression of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders (e.g., multiple sclerosis, Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis), cerebral vascular accidents, head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, particularly to opiates, alcohol, and nicotine. The compounds are also useful for the treatment of obesity or eating disorders associated with excessive food intake and complications associated therewith.
